Search

everythinglearnresearchcommunity

for

Search:↓

Balancing hormones can help women feel youthful and healthy.

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.

Alopecia patients have less GPER-1, which might affect hair loss.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Healthy women tend to lose more hair in July and April, and the least in February.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Caucasian women's hair appears thickest in their 20s, with perceived thinning after mid-30s due to both decreasing density and diameter.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

A woman with a new PTCH gene mutation has both Gorlin syndrome and severe hair loss.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Obese women with PCOS are more likely to have fatty liver disease.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Finasteride improves hair density and thickness in women with hair loss.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

The dietary supplement helped increase hair growth in women with hair loss.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Finasteride may help some women with hair loss, but better options exist.

Low prolactin in young women may increase heart and metabolism risks.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.